Author

Ryan R. Gordon

Oregon Health & Science University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Abhinandan PattanayakiD· 1 shared Amarnath NatarajaniD· 1 shared Fangfang QiaoiD· 1 shared Jaclyn Knibbe· 1 shared Katelyn L. O’NeilliD· 1 shared Prathap Reddy Mukthapuram· 1 shared Raymond C. BerganiD· 1 shared Weining CheniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhinandan PattanayakORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A New Class of Precision Therapeutics that Inhibit Prostate Cancer Mediated Bone Destruction

Fangfang Qiao, Ryan R. Gordon, Abhinandan Pattanayak, Wenqi Li, Jaclyn Knibbe, Katelyn L. O’Neill, Weining Chen, Prathap Reddy Mukthapuram, Amarnath Natarajan, Raymond C. Bergan

This paper develops BTE-EN1, a compound that inhibits prostate cancer-mediated bone destruction by targeting cell motility and osteoclast activity, showing efficacy in mice.

bioRxiv · May 20, 2025 · PreprintCancer Biology